These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 9235987

  • 1. Synthesis, stereochemistry, and biological activity of 1alpha,23,25-trihydroxy-24-oxovitamin D3, a major natural metabolite of 1alpha,25-dihydroxyvitamin D3.
    Lee NE, Reddy GS, Brown AJ, Williard PG.
    Biochemistry; 1997 Aug 05; 36(31):9429-37. PubMed ID: 9235987
    [Abstract] [Full Text] [Related]

  • 2. 1Alpha,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of 1alpha,25-dihydroxyvitamin D3, is a potent suppressor of parathyroid hormone secretion.
    Brown AJ, Ritter C, Slatopolsky E, Muralidharan KR, Okamura WH, Reddy GS.
    J Cell Biochem; 1999 Apr 01; 73(1):106-13. PubMed ID: 10088729
    [Abstract] [Full Text] [Related]

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 01; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 4. C-25 hydroxylation of 1alpha,24(R)-dihydroxyvitamin D3 is catalyzed by 25-hydroxyvitamin D3-24-hydroxylase (CYP24A1): metabolism studies with human keratinocytes and rat recombinant CYP24A1.
    Astecker N, Bobrovnikova EA, Omdahl JL, Gennaro L, Vouros P, Schuster I, Uskokovic MR, Ishizuka S, Wang G, Reddy GS.
    Arch Biochem Biophys; 2004 Nov 15; 431(2):261-70. PubMed ID: 15488475
    [Abstract] [Full Text] [Related]

  • 5. 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3 and 1alpha,25-dihydroxy-16-ene-23-yne-20-epi-vitamin D3: analogs of 1alpha,25-dihydroxyvitamin D3 that resist metabolism through the C-24 oxidation pathway are metabolized through the C-3 epimerization pathway.
    Reddy GS, Rao DS, Siu-Caldera ML, Astecker N, Weiskopf A, Vouros P, Sasso GJ, Manchand PS, Uskokovic MR.
    Arch Biochem Biophys; 2000 Nov 15; 383(2):197-205. PubMed ID: 11185554
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The vitamin D prodrugs 1alpha(OH)D2, 1alpha(OH)D3 and BCI-210 suppress PTH secretion by bovine parathyroid cells.
    Brown AJ, Ritter CS, Knutson JC, Strugnell SA.
    Nephrol Dial Transplant; 2006 Mar 15; 21(3):644-50. PubMed ID: 16221703
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and biological activities of the two C(23) epimers of 1alpha,23,25-trihydroxy-24-oxo-19-nor-vitamin D(3): novel analogs of 1alpha,23(S),25-trihydroxy-24-oxo-vitamin D(3), a natural metabolite of 1alpha,25-dihydroxyvitamin D(3).
    Lee NE, Williard PG, Brown AJ, Campbell MJ, Koeffler HP, Peleg S, Rao DS, Reddy GS.
    Steroids; 2000 May 15; 65(5):252-65. PubMed ID: 10751637
    [Abstract] [Full Text] [Related]

  • 9. Roles of the structure and orientation of ligands and ligand mimics inside the ligand-binding pocket of the vitamin D-binding protein.
    Swamy N, Dutta A, Ray R.
    Biochemistry; 1997 Jun 17; 36(24):7432-6. PubMed ID: 9200691
    [Abstract] [Full Text] [Related]

  • 10. Isolation and identification of 1alpha-hydroxy-3-epi-vitamin D3, a potent suppressor of parathyroid hormone secretion.
    Brown AJ, Ritter CS, Weiskopf AS, Vouros P, Sasso GJ, Uskokovic MR, Wang G, Reddy GS.
    J Cell Biochem; 2005 Oct 15; 96(3):569-78. PubMed ID: 16088954
    [Abstract] [Full Text] [Related]

  • 11. New 1alpha,25-dihydroxy-19-norvitamin D3 compounds of high biological activity: synthesis and biological evaluation of 2-hydroxymethyl, 2-methyl, and 2-methylene analogues.
    Sicinski RR, Prahl JM, Smith CM, DeLuca HF.
    J Med Chem; 1998 Nov 05; 41(23):4662-74. PubMed ID: 9804706
    [Abstract] [Full Text] [Related]

  • 12. Removal of C-ring from the CD-ring skeleton of 1alpha,25-dihydroxyvitamin D3 does not alter its target tissue metabolism significantly.
    Reddy GS, Robinson M, Wang G, Palmore GT, Gennaro L, Vouros P, De Clercq P, Vandewalle M, Young W, Ling S, Verstuyf A, Bouillon R.
    Arch Biochem Biophys; 2007 Apr 15; 460(2):254-61. PubMed ID: 17196157
    [Abstract] [Full Text] [Related]

  • 13. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
    Chen TC, Schwartz GG, Burnstein KL, Lokeshwar BL, Holick MF.
    Clin Cancer Res; 2000 Mar 15; 6(3):901-8. PubMed ID: 10741714
    [Abstract] [Full Text] [Related]

  • 14. Novel 2-alkyl-1alpha,25-dihydroxy-19-norvitamin D3: efficient synthesis with Julia olefination, evaluation of biological activity and development of new analyzing system for co-activator recruitment.
    Arai MA, Kittaka A.
    Anticancer Res; 2006 Mar 15; 26(4A):2621-31. PubMed ID: 16886672
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and evaluation of a 3-position diastereomer of 1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin D3 (ED-71).
    Hatakeyama S, Nagashima S, Imai N, Takahashi K, Ishihara J, Sugita A, Nihei T, Saito H, Takahashi F, Kubodera N.
    Bioorg Med Chem; 2006 Dec 01; 14(23):8050-6. PubMed ID: 16908172
    [Abstract] [Full Text] [Related]

  • 16. Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3.
    Schwartz GG, Whitlatch LW, Chen TC, Lokeshwar BL, Holick MF.
    Cancer Epidemiol Biomarkers Prev; 1998 May 01; 7(5):391-5. PubMed ID: 9610788
    [Abstract] [Full Text] [Related]

  • 17. Comparison between 1alpha(OH)D3 and 1,25(OH)2D3 on the suppression of plasma PTH levels in uremic patients, evaluated by the 'whole' and 'intact' PTH assays.
    Brandi L, Egfjord M, Olgaard K.
    Nephron Clin Pract; 2005 May 01; 99(4):c128-37. PubMed ID: 15722644
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and metabolic studies of 1α,2α,25-, 1α,4α,25- and 1α,4β,25-trihydroxyvitamin D3.
    Takano M, Sawada D, Yasuda K, Nishikawa M, Takeuchi A, Takagi K, Horie K, Reddy GS, Chen TC, Sakaki T, Kittaka A.
    J Steroid Biochem Mol Biol; 2015 Apr 01; 148():34-7. PubMed ID: 25263656
    [Abstract] [Full Text] [Related]

  • 19. Metabolic stability of 3-epi-1α,25-dihydroxyvitamin D3 over 1 α 25-dihydroxyvitamin D3: metabolism and molecular docking studies using rat CYP24A1.
    Rhieu SY, Annalora AJ, Wang G, Flarakos CC, Gathungu RM, Vouros P, Sigüeiro R, Mouriño A, Schuster I, Palmore GT, Reddy GS.
    J Cell Biochem; 2013 Oct 01; 114(10):2293-305. PubMed ID: 23606409
    [Abstract] [Full Text] [Related]

  • 20. Human keratinocyte line HaCaT metabolizes 1alpha-hydroxyvitamin D3 and vitamin D3 to 1alpha,25-dihydroxyvitamin D3 (calcitriol).
    Lehmann B, Pietzsch J, Kämpf A, Meurer M.
    J Dermatol Sci; 1998 Nov 01; 18(2):118-27. PubMed ID: 9833978
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.